Determination of Lovastatin Concentration in Human Plasma by High Performance Liquid Chromatography-Electrospray Mass Spectrometry

YU Yun-qiu,HUANG Jian-ming,WENG Wei-yu,GU Li-hua,WANG Yi-jian,ZHANG Li
DOI: https://doi.org/10.3969/j.issn.1007-7669.2005.12.008
2005-01-01
Abstract:AIM: To develop a high-performance liquid chromatography-mass spectrometry (HPLC-MS) method for the determination of lovastatin concentration in human plasma. METHODS: The chromatographic separation was performed on a Diamonsil C_ 18 column (5 μm, 2.1 mm×150 mm) at 40 ℃. The mobile phase, a mixture of acetonitrile ∶water (60 ∶40), was delivered at a flow-rate of 0.4 mL·min -1. MS detection in single ion monitoring mode (SIM) using electrospray ionization (ESI) as an interface was applied to determine positive ions at m/z 405 for lovastatin and m/z 419 for internal standard (IS, simvastatin). Lovastatin and IS were isolated by a liquid-liquid extraction using cyclohexane: methylene dichloride (3 ∶1) as the solvent. RESULTS: High specificity and a low quantitation limit (0.1 μg·L -1) were achieved. Linearity was confirmed in the concentration range of 0.5-50 μg·L -1 with the correlation coefficient (r)=0.998 9. The relative standard deviation (RSD) values of intra- and inter-day assay were less than 14.47 % and the recoveries were within 88.12 %-112.09 %. The extraction recovery of lovastatin was ranged from 76.28 % to 77.15 %. CONCLUSION: HPLC-MS method is sensitive, specific and applicable to pharmacokinetic studies of lovastatin in human.
What problem does this paper attempt to address?